2022. A Pilot Study, to Evaluate the Safety and Efficacy of Topically Applied Onabotulinum Toxin A Delivered through a Novel Iontophoresis Device in Subjects with Axillary Hyperhidrosis. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s106. DOI:https://doi.org/10.25251/skin.6.supp.106.